Genome engineering company Replay and The University of Texas’ MD Anderson Cancer Center have joined forces to launch Syena, an oncology product company.
https://www.pharmalive.com/wp-content/uploads/2023/02/BioSpaceMDAnderson2-15-2023.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2023-02-15 11:57:432023-02-15 11:57:43Replay, MD Anderson partner to create first engineered cell therapy for solid tumors
